DRD1 and schizophrenia: The DA hypothesis of schizophrenia assumes that positive symptoms can be attributed to the hyperactivity of dopamine D2 receptors in the subcortical and limbic brain regions, while negative symptoms can be attributed to the hypo functionality of dopamine D1 receptors neurotransmission in PFC (37).